Works matching IS 03407004 AND DT 2012 AND VI 61 AND IP 12


Results: 17
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Phase II trial of hu14.18-IL2 for patients with metastatic melanoma.

    Published in:
    Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2261, doi. 10.1007/s00262-012-1286-5
    By:
    • Albertini, Mark;
    • Hank, Jacquelyn;
    • Gadbaw, Brian;
    • Kostlevy, Jordan;
    • Haldeman, Jennifer;
    • Schalch, Heidi;
    • Gan, Jacek;
    • Kim, KyungMann;
    • Eickhoff, Jens;
    • Gillies, Stephen;
    • Sondel, Paul
    Publication type:
    Article
    11
    12
    13
    14
    15
    16

    Effective modulation of CD4CD25 regulatory T and NK cells in malignant patients by combination of interferon-α and interleukin-2.

    Published in:
    Cancer Immunology, Immunotherapy, 2012, v. 61, n. 12, p. 2357, doi. 10.1007/s00262-012-1297-2
    By:
    • Liu, Guangxian;
    • Yang, Wuwei;
    • Guo, Mei;
    • Liu, Xiaoqing;
    • Huang, Naixiang;
    • Li, Dingfeng;
    • Jiang, Zefei;
    • Yang, Wenfeng;
    • Zhang, Weijing;
    • Su, Hang;
    • Liu, Zhiqing;
    • Liu, Tieqiang;
    • Wang, Dongmei;
    • Huang, Shan;
    • Yao, Bo;
    • Man, Qiuhong;
    • Qiu, Lijuan;
    • Sun, Xuedong;
    • Sun, Yuying;
    • Liu, Bing
    Publication type:
    Article
    17